Back to list

Dermatology- June

Sneak Peek: What’s Hot at the WPD!

We’re back in your inbox this month with a sneak peek edition of MedscapeLIVE! Dermatology. We’ve got several faculty of Medscape’s 18th Annual Women’s & Pediatric Dermatology Seminar

with us, including Dr. Brian Hibler, Dr. Melinda Jen, Dr. Mercedes Gonzalez, and Dr. Ted Rosen.

This conference covers the latest advancements in women’s and pediatric dermatology from atopic dermatitis, psoriasis, and hair loss to acne and rosacea. Here we discuss some learning opportunities and clinical pearls that attendees can bring back to their practices. 

Last month, faculty of the Inaugural PDE Symposium shared some guidance on pigment disorders. If you missed it, you can find that interview here.

Also, don’t miss this month’s Derm Resource section that includes articles from JAMA Dermatology, Dermatology News, Cutis, and NEJM

Thank you to our doctors this month for giving us a sneak peek into this conference! Please contact me at colleen@cmhadvisors.com with any feedback, comments, or suggestions, and thanks again for reading!—Colleen Hutchinson

Sneak Peek: What’s Hot at the 18th Annual Women’s & Pediatric Dermatology Seminar!

Can you share a couple of pearls from your presentation, Vulvar Dermatology: Infections and More:

Dr. Rosen: When considering a vulvar ulcer, don't forget syphilis, which is resurgent in the US. But remember, there is a broad differential diagnosis involved, and a biopsy may be required to accurately establish a diagnosis.

Benign vulvar melanosis may suggest malignant melanoma. However, this benign entity is characterized by indolent, asymptomatic, clustered pigmented macules.

How about from your second presentation, The Latest on STDs in 2023:

Dr. Rosen: Genital herpes or external genital warts in children should arouse suspicion for both sexual abuse and the potential for sex trafficking.

Sequential use of cryosurgery followed by application of sinecatechins 15% ointment has recently been shown to be very effective and well tolerated for external genital warts in women.

Are there any presentations or sessions in particular that you’re looking forward to?

Dr. Rosen: I am looking forward to hearing Pediatric Emergencies by Anna Yasmine Kirkorian, MD. One can never be too prepared for urgent and emergent disorders, both in terms of diagnosis and treatment.

Can you share any headlines from your presentation, Approaching the Aging Face:

Dr. Hibler: Despite being around for many years now, we are constantly learning new facts about facial aging to refine our technique with injectable neuromodulators and fillers. Additionally, we are seeing younger patients presenting for treatment, or even prevention, of signs of aging, including lines and wrinkles. Patient safety is paramount, followed by gauging patient expectations and tailoring treatments to their concerns and desired aesthetic. We will review some new advancements in neuromodulators and safe injection techniques for dermal fillers to drive optimal results.

What are some pearls from your presentation, Procedural Aesthetics: Beyond Botulinum Toxin A and Fillers:

Dr. Hibler: We are seeing an increasing demand for non-invasive body contouring treatments. We have many devices capable of fat reduction, muscle toning, and tissue tightening which we can employ to give more definition to various anatomic zones. Major areas of concern include the submental area and jawline, abdomen, and thigh/buttocks. Understanding how we might combine treatments and tailor them to our patients can help provide the best outcomes and excellent patient satisfaction.

Are there any presentations or sessions you’re looking forward to?

Dr. Hibler: I'm looking forward to the discussion on skin conditions in skin of color. I always learn new pearls for diagnosing skin conditions and making over-the-counter recommendations for the unique skin and hair concerns of my patients.

What will be a headline in your presentation, Lumps and Bumps:

Dr. Jen: Appropriately identifying which congenital lesions require further imaging is critical to diagnose developmental anomalies such as encephaloceles, nasal gliomas, and occult spinal dysraphism.

What are some pearls from your presentation, Vascular Lesions Update:

Dr. Jen: There have been exciting advances in vascular anomalies as we learn more about the underlying genetic causes. Not only do we have a better understanding about how different clinical phenotypes are genetically related, but we can translate that knowledge into identifying targeted therapeutics.

Can you share a couple of pearls from your presentation, Warts—New Innovations in the Treatment of Warts and Molluscum Contagiosum:

Dr. Gonzalez: There are new treatments on the horizon for molluscum in pediatric patients:  VP-102 (in office) and Berdazimer gel (at home topical) have shown safety and efficacy over placebo for molluscum clearance at 12 weeks and are under review for FDA approval.

How about from your second presentation, Spring and Summer Eruptions:

Dr. Gonzalez: Ozenoxacin 1% cream is a novel topical quinolone effective against S.aureus, S. Pyogenes, and MRSA, as well as mupirocin resistant S. aureus and cipro resistant S. aureus.

Also, oxybenzone is no longer used in new sunscreens in Europe, and in the US the FDA is requiring more information before determining GRASE status. 

Mineral sunscreens can be used on infants less than 6 months of age to areas of skin uncovered by clothing and hats, if adequate clothing and shade are not available.

Are there any presentations or sessions in particular that you’re looking forward to?

Dr. Gonzalez: I am most looking forward to the hair sessions, as there is so much going on in this arena. 

Dermatology Resource Section: 

Cutis Original Research: Interacting With Dermatology Patients Online: Private Practice vs Academic Institute Website Content


NEJM Review Article: Squamous-Cell Carcinoma of the Skin


Dermatology News Conference Coverage: ‘New standard of care’ for capecitabine hand-foot syndrome


JAMA Dermatology Editorial: Public Health and Diagnostic Approaches to Risk Stratification for Melanoma


Cutis Article: Cross-sectional Analysis of Matched Dermatology Residency Applicants Without US Home Programs